NCT04547010

Brief Summary

Low bone mineral density (BMD) has recently increased among young women. Soy Isoflavone as a food supplement, has been found to have potent effect on bone health in postmenopausal women. However, the effect of soy isoflavone on pre-menopausal is not well understood. This research is done to examine the effect of soy isoflavones on BMD among young university female students.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Dec 2018

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2019

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

September 6, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 14, 2020

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

3 months

First QC Date

September 6, 2020

Last Update Submit

September 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bone Mineral Density (BMD)

    4 weeks

Study Arms (1)

Intervention group

EXPERIMENTAL

In four weeks of intervention study the participants instructed to receive (60 mg) of soy-isoflavone supplement per day, after this period the Bone Mineral Density was assessed by Dual X-ray Absorptiometry scan to evaluate the effect of soy-isoflavone supplement on Bone mineral density.

Dietary Supplement: Soy Isoflavone supplement

Interventions

Soy Isoflavone supplementDIETARY_SUPPLEMENT

Participants received 60 mg of soy-isoflavone supplement per day.

Intervention group

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • female
  • University students
  • aged between 18-25 years

You may not qualify if:

  • Study participants who use medications and suffer from diseases that may interfere or effect on BMD, use calcium and vitamin D supplements and who suffer from glucose 6 phosphate deficiency (G6PD) were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imam Abdulrahman Bin Faisal University

Dammam, Eastern Province, 34221, Saudi Arabia

Location

MeSH Terms

Conditions

Bone Diseases, MetabolicOsteosclerosis

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesOsteochondrodysplasiasBone Diseases, Developmental

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Pre-post Quasi experimental study design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 6, 2020

First Posted

September 14, 2020

Study Start

December 12, 2018

Primary Completion

March 15, 2019

Study Completion

March 15, 2019

Last Updated

September 28, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations